Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2753 results

Sort By:

Preserving Ability Through Virtual Exercise (PAVE)

Study ID: NCT07189286
Start Date: 2026-01-01
End Date: 2030-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

140

Intervention / Treatment

PAVE intervention

Education control

Sponsor

University of Maryland, Baltimore

Source: clinicaltrials.gov

Share:
Add to list

A Cataract Surgery Clinical Trial

Study ID: NCT07044674
Start Date: 2026-02
End Date: 2026-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

125

Intervention / Treatment

UNITY Vitreoretinal Cataract System

CENTURION Vision System with Active Sentry

Anterior segment ophthalmic surgery

Sponsor

Alcon Research

Source: clinicaltrials.gov

Share:
Add to list

Allogeneic, Antigen-Presenting, GM-CSF-secreting, SV-BR-1-GM Whole Cell-Therapeutic Vaccine and Immunotherapy: A Phase I Pilot Safety and Feasibility Study for Solid Tumor Patients With CNS Metastases

Study ID: NCT07199413
Start Date: 2026-03-01
End Date: 2029-04-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

SV-BR-1-GM Vaccine

Cyclophosphamide

Pembrolizumab

Interferon

Sponsor

Medical College of Wisconsin

Source: clinicaltrials.gov

Share:
Add to list

Remote Assessment of Digital Neurologic Testing

Study ID: NCT07014982
Start Date: 2026-02-01
End Date: 2026-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Guided Meditation

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC

Study ID: NCT07155850
Start Date: 2026-01
End Date: 2027-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Medical device containing Y-90 microspheres delivered intratumorally and percutaneously into the pancreas

Sponsor

BetaGlue Therapeutics SpA

Source: clinicaltrials.gov

Share:
Add to list

Virtual Reality in Electrophysiological Procedures and Device Implantation: the VR inEP Trial

Study ID: NCT07105241
Start Date: 2025-11-15
End Date: 2026-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

115

Intervention / Treatment

VR therapy

360 degree education videos

Sponsor

Radboud University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

A Study for the PanCystPro Assay in the Management of Pancreatic Cystic Lesions

Study ID: NCT06894329
Start Date: 2025-12-15
End Date: 2027-03-16
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment
Sponsor

Amplified Sciences Inc

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.

Study ID: NCT05776927
Start Date: 2026-02-01
End Date: 2029-02-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

304

Intervention / Treatment

QVM149

Salmeterol Xinafoate / Fluticasone Propionate

Placebo to QVM149

Placebo to Salmeterol Xinafoate / Fluticasone Propionate

Run-In Medication

Rescue Medication

Concept 1 Device

Girohaler

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of the School-based SIM Program in Upper Secondary School Students

Study ID: NCT07111676
Start Date: 2026-12-01
End Date: 2027-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

560

Intervention / Treatment

The Solution-focused Intervention for Mental health (SIM)

Sponsor

Region Örebro County

Source: clinicaltrials.gov

Share:
Add to list

Use of a New Smartphone Application to Determine Changes in Eyeblink Conditioning From Home Training in Individuals With Spinocerebellar Ataxia

Study ID: NCT06177626
Start Date: 2026-01
End Date: 2027-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Aerobic Training

Balance Training

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list